praziquantel has been researched along with Inflammation in 28 studies
azinox: Russian drug
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This cohort study assessed urinary eosinophil cationic protein (ECP) as an indicator for urinary tract morbidity and inflammation indication related to single-dose or dual-dose praziquantel (PZQ) treatment." | 7.85 | Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein. ( Fofana, HKM; Keita, AD; Landouré, A; Madsen, H; Reimert, CM; Sacko, M; Stecher, CW; Traoré, MS; Vennervald, BJ; Wilson, S, 2017) |
| " Aspirin has many properties including anti-inflammation and anti-cancer." | 7.83 | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. ( Aukkanimart, R; Boonmars, T; Jiraporn, S; Loilome, W; Nadchanan, W; Namwat, N; Ruangjirachuporn, W; Sriraj, P; Sudsarn, P, 2016) |
| "Taken together, these data suggest that the combined treatment of PZQ and edelfosine promotes a high decrease in granuloma formation, as well as in the cellular immune response that underlies granuloma development, with changes in the cytokine patterns, and may provide a promising and effective strategy for a prophylactic treatment of schistosomiasis." | 7.81 | Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel. ( López-Abán, J; Mollinedo, F; Muro, A; Rojas-Caraballo, J; Varela-M, RE; Yepes, E, 2015) |
| "A 59-year-old man with known neurocysticercosis developed a large cerebral infarction during praziquantel therapy." | 7.69 | Large cerebral infarction during praziquantel therapy in neurocysticercosis. ( Bang, OY; Choi, SA; Heo, JH; Kim, DI, 1997) |
| "Curcumin-treated groups, with and without PZQ, resulted in higher significant Immunoreactivity score (IRS) for Bcl-2-associated X (BAX) and lower Interleukine- 17A (IL-17A), and Human epidermal growth factor (EGF), compared to the control." | 5.72 | Potentiality of curcumin on ISHAK scoring system and the expressions of BAX, IL-17A, and EGF in the treatment ofSchistosoma mansoni infection using Swiss albino mice. ( Abd-Elaal, AA; Amin, NM; El Saftawy, EA; El-Dardiry, MA; Negm, MSI, 2022) |
| " We investigated systemic inflammation as measured by plasma levels of soluble tumor necrosis factor-alpha receptor II (sTNF-rII), interleukin-8, (IL-8), and IL-10 during schistosomiasis and HIV co-infection and after schistosomiasis treatment." | 5.13 | Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis. ( Butterworth, AE; Deelder, AM; Erikstrup, C; Gerstoft, J; Gomo, E; Kallestrup, P; Ostrowski, SR; Pedersen, BK; Ullum, H; van Dam, GJ; Zinyama-Gutsire, RB, 2008) |
| " Antischistosomal therapy, praziquantel, used for pulmonary hypertension secondary to schistosomiasis usually has no effect, but it is given to prevent further progression of disease." | 4.86 | Pulmonary vascular disease associated with schistosomiasis. ( Butrous, G; Crosby, A; Harhay, MO; Kolosionek, E; Morrell, N, 2010) |
| " This study aimed to investigate baseline Schistosoma mansoni-Circulating Anodic Antigen (CAA) levels and their association with kidney biomarkers related to podocyte injury and inflammation in long-term follow-up after praziquantel (PZQ) treatment." | 4.31 | Subclinical signs of podocyte injury associated with Circulating Anodic Antigen (CAA) in Schistosoma mansoni-infected patients in Brazil. ( Bezerra, FSM; Corstjens, PLAM; Daher, EF; Dam, GJV; Galvão, RLF; Martins, AMC; Meneses, GC; Pinheiro, MCC; Sousa, MS, 2023) |
| "This cohort study assessed urinary eosinophil cationic protein (ECP) as an indicator for urinary tract morbidity and inflammation indication related to single-dose or dual-dose praziquantel (PZQ) treatment." | 3.85 | Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein. ( Fofana, HKM; Keita, AD; Landouré, A; Madsen, H; Reimert, CM; Sacko, M; Stecher, CW; Traoré, MS; Vennervald, BJ; Wilson, S, 2017) |
| " Aspirin has many properties including anti-inflammation and anti-cancer." | 3.83 | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. ( Aukkanimart, R; Boonmars, T; Jiraporn, S; Loilome, W; Nadchanan, W; Namwat, N; Ruangjirachuporn, W; Sriraj, P; Sudsarn, P, 2016) |
| "Taken together, these data suggest that the combined treatment of PZQ and edelfosine promotes a high decrease in granuloma formation, as well as in the cellular immune response that underlies granuloma development, with changes in the cytokine patterns, and may provide a promising and effective strategy for a prophylactic treatment of schistosomiasis." | 3.81 | Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel. ( López-Abán, J; Mollinedo, F; Muro, A; Rojas-Caraballo, J; Varela-M, RE; Yepes, E, 2015) |
| "A 59-year-old man with known neurocysticercosis developed a large cerebral infarction during praziquantel therapy." | 3.69 | Large cerebral infarction during praziquantel therapy in neurocysticercosis. ( Bang, OY; Choi, SA; Heo, JH; Kim, DI, 1997) |
| " INTERPRETATION/SIGNIFICANCE: PZQ treatment is as safe and efficacious in children aged 1-5 years as it is in older children aged 6-10 years in whom PZQ is the drug of choice for control of schistosome infections." | 2.76 | Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. ( Appleby, L; Bourke, C; Mduluza, T; Midzi, N; Mitchell, K; Mutapi, F; Nausch, N; Rujeni, N, 2011) |
| "Curcumin-treated groups, with and without PZQ, resulted in higher significant Immunoreactivity score (IRS) for Bcl-2-associated X (BAX) and lower Interleukine- 17A (IL-17A), and Human epidermal growth factor (EGF), compared to the control." | 1.72 | Potentiality of curcumin on ISHAK scoring system and the expressions of BAX, IL-17A, and EGF in the treatment ofSchistosoma mansoni infection using Swiss albino mice. ( Abd-Elaal, AA; Amin, NM; El Saftawy, EA; El-Dardiry, MA; Negm, MSI, 2022) |
| "Vesical paragonimiasis is an extremely rare form of ectopic infestation caused by Paragonimus spp." | 1.40 | Vesical paragonimiasis diagnosed by histopathology: a case report. ( Han, P; Li, X; Liu, L; Wei, Q; Wei, X; Yue, X; Zhu, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 16 (57.14) | 24.3611 |
| 2020's | 6 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Zanet, S | 1 |
| Morelli, S | 1 |
| Di Cesare, A | 1 |
| Bò, S | 1 |
| Traversa, D | 1 |
| Lebon, W | 1 |
| Beugnet, F | 1 |
| Simonato, G | 1 |
| Ferroglio, E | 1 |
| El Saftawy, EA | 1 |
| El-Dardiry, MA | 1 |
| Abd-Elaal, AA | 1 |
| Negm, MSI | 1 |
| Amin, NM | 1 |
| Steuer, AE | 1 |
| Scoggin, K | 1 |
| Stewart, JC | 1 |
| Barker, VD | 1 |
| Adams, AA | 1 |
| Loynachan, AT | 1 |
| Nielsen, MK | 1 |
| Elhenawy, AA | 1 |
| Elmehankar, MS | 1 |
| Nabih, N | 1 |
| Elzoheiry, MA | 1 |
| Hany, H | 1 |
| El-Gamal, R | 1 |
| Aboukamar, WA | 1 |
| Sousa, MS | 1 |
| Meneses, GC | 1 |
| Dam, GJV | 1 |
| Corstjens, PLAM | 1 |
| Galvão, RLF | 1 |
| Pinheiro, MCC | 1 |
| Martins, AMC | 1 |
| Daher, EF | 1 |
| Bezerra, FSM | 1 |
| Shen, J | 1 |
| Wang, L | 1 |
| Peng, M | 1 |
| Liu, Z | 1 |
| Zhang, B | 1 |
| Zhou, T | 1 |
| Sun, X | 1 |
| Wu, Z | 1 |
| Santos, MP | 1 |
| Gonçalves-Santos, E | 1 |
| Gonçalves, RV | 2 |
| Santos, EC | 1 |
| Campos, CC | 2 |
| Bastos, DSS | 1 |
| Marques, MJ | 2 |
| Souza, RLM | 2 |
| Novaes, RD | 2 |
| Wilgus, NC | 1 |
| Williams, P | 1 |
| Bolesta, ES | 1 |
| Chamberland, RR | 1 |
| Garcia, HH | 3 |
| Del Brutto, OH | 1 |
| Stecher, CW | 1 |
| Fofana, HKM | 1 |
| Madsen, H | 1 |
| Wilson, S | 1 |
| Keita, AD | 1 |
| Landouré, A | 1 |
| Traoré, MS | 1 |
| Vennervald, BJ | 1 |
| Reimert, CM | 1 |
| Sacko, M | 1 |
| Mahanty, S | 3 |
| Orrego, MA | 1 |
| Cangalaya, C | 2 |
| Adrianzen, MP | 1 |
| Arroyo, G | 1 |
| Calcina, J | 1 |
| Gonzalez, AE | 2 |
| Guerra-Giraldez, C | 2 |
| Nash, TE | 3 |
| Toledo, A | 1 |
| Osorio, R | 1 |
| Matus, C | 1 |
| Martinez Lopez, Y | 1 |
| Ramirez Cruz, N | 1 |
| Sciutto, E | 1 |
| Fragoso, G | 1 |
| Arauz, A | 1 |
| Carrillo-Mezo, R | 1 |
| Fleury, A | 1 |
| Ware, JM | 1 |
| Coyle, CM | 1 |
| Dias, MV | 1 |
| Castro, AP | 1 |
| Souza-Silva, TG | 1 |
| Yue, X | 1 |
| Wei, X | 1 |
| Zhu, Y | 1 |
| Han, P | 1 |
| Li, X | 1 |
| Wei, Q | 1 |
| Liu, L | 1 |
| Yepes, E | 1 |
| Varela-M, RE | 1 |
| López-Abán, J | 1 |
| Rojas-Caraballo, J | 1 |
| Muro, A | 1 |
| Mollinedo, F | 1 |
| Sudsarn, P | 1 |
| Boonmars, T | 1 |
| Ruangjirachuporn, W | 1 |
| Namwat, N | 1 |
| Loilome, W | 1 |
| Sriraj, P | 1 |
| Aukkanimart, R | 1 |
| Nadchanan, W | 1 |
| Jiraporn, S | 1 |
| Zimic, M | 1 |
| Marzal, M | 1 |
| Erikstrup, C | 1 |
| Kallestrup, P | 1 |
| Zinyama-Gutsire, RB | 1 |
| Gomo, E | 1 |
| van Dam, GJ | 1 |
| Deelder, AM | 1 |
| Butterworth, AE | 1 |
| Pedersen, BK | 1 |
| Ostrowski, SR | 1 |
| Gerstoft, J | 1 |
| Ullum, H | 1 |
| Landeyro, J | 1 |
| Elguezabal, A | 1 |
| Gené, M | 1 |
| García-Fontgivell, J | 1 |
| Mayayo, E | 1 |
| Kolosionek, E | 1 |
| Crosby, A | 1 |
| Harhay, MO | 1 |
| Morrell, N | 1 |
| Butrous, G | 1 |
| Mutapi, F | 1 |
| Rujeni, N | 1 |
| Bourke, C | 1 |
| Mitchell, K | 1 |
| Appleby, L | 1 |
| Nausch, N | 1 |
| Midzi, N | 1 |
| Mduluza, T | 1 |
| Leenstra, T | 1 |
| Coutinho, HM | 1 |
| Acosta, LP | 1 |
| Langdon, GC | 1 |
| Su, L | 1 |
| Olveda, RM | 1 |
| McGarvey, ST | 1 |
| Kurtis, JD | 1 |
| Friedman, JF | 1 |
| Rosin, MP | 1 |
| Saad el Din Zaki, S | 1 |
| Ward, AJ | 1 |
| Anwar, WA | 1 |
| Bang, OY | 1 |
| Heo, JH | 1 |
| Choi, SA | 1 |
| Kim, DI | 1 |
| Jung, H | 1 |
| Hurtado, M | 1 |
| Medina, MT | 1 |
| Sanchez, M | 1 |
| Sotelo, J | 1 |
| Byram, JE | 1 |
| Harrison, RA | 1 |
| von Lichtenberg, F | 1 |
| Webbe, G | 1 |
| Sturrock, RF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment[NCT02495909] | 700 participants (Actual) | Observational | 2016-02-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for praziquantel and Inflammation
| Article | Year |
|---|---|
Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Topics: Albendazole; Anticestodal Agents; Antiparasitic Agents; Brain; Cysts; Epilepsy; Female; Humans; Infl | 2017 |
Pulmonary vascular disease associated with schistosomiasis.
Topics: Animals; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Portal; Hypertension | 2010 |
Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients.
Topics: Cell Division; DNA Damage; Humans; Inflammation; Micronucleus Tests; Praziquantel; Schistosomiasis; | 1994 |
3 trials available for praziquantel and Inflammation
| Article | Year |
|---|---|
Efficacy of fipronil/(S)-methoprene/eprinomectin/praziquantel (Broadline
Topics: Animals; Antiparasitic Agents; Cat Diseases; Cats; Drug Combinations; Eye; Female; Inflammation; Ive | 2021 |
Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis.
Topics: Adolescent; Adult; Cohort Studies; Cross-Sectional Studies; Cytokines; Female; HIV Infections; HIV-1 | 2008 |
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
Topics: Administration, Oral; Animals; Anthelmintics; Appetite; Child; Child, Preschool; Feeding and Eating | 2011 |
22 other studies available for praziquantel and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Potentiality of curcumin on ISHAK scoring system and the expressions of BAX, IL-17A, and EGF in the treatment ofSchistosoma mansoni infection using Swiss albino mice.
Topics: Animals; Anthelmintics; bcl-2-Associated X Protein; Curcumin; Epidermal Growth Factor; Granuloma; In | 2022 |
Comparison of the host response to larvicidal and nonlarvicidal treatment of naturally acquired cyathostomin infections in horses.
Topics: Animals; Anthelmintics; Feces; Horse Diseases; Horses; Inflammation; Ivermectin; Larva; Macrolides; | 2022 |
Biochanin A in murine
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents; Fibrosis; Inflammation; Liver; Mice; Oxidative Str | 2023 |
Subclinical signs of podocyte injury associated with Circulating Anodic Antigen (CAA) in Schistosoma mansoni-infected patients in Brazil.
Topics: Animals; Antigens, Helminth; Brazil; Humans; Inflammation; Podocytes; Praziquantel; Prevalence; Schi | 2023 |
Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model.
Topics: Animals; Anthelmintics; Disease Models, Animal; Fibrosis; Granuloma; Helminth Proteins; Immunologic | 2019 |
Doxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection.
Topics: Airway Remodeling; Animals; Anthelmintics; Cytokines; Disease Models, Animal; Doxycycline; Granuloma | 2021 |
Photo Quiz: A 46-Year-Old Man with a Lung Mass and History of Hemoptysis.
Topics: Anthelmintics; Anti-Bacterial Agents; Biopsy; Hemoptysis; Humans; Inflammation; Lung; Male; Middle A | 2017 |
Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein.
Topics: Adolescent; Adult; Animals; Anthelmintics; Biomarkers; Child; Child, Preschool; Cohort Studies; Eosi | 2017 |
TNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.
Topics: Animals; Anticestodal Agents; Antiparasitic Agents; Blood-Brain Barrier; Brain; Cytokines; Dexametha | 2017 |
Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host…but Also the Parasite.
Topics: Adrenal Cortex Hormones; Animals; Anthelmintics; Biomarkers; Brain; Drug Therapy, Combination; Foodb | 2018 |
Etanercept to Control Inflammation in the Treatment of Complicated Neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Etanercept; Female; Huma | 2019 |
Doxycycline hyclate: A schistosomicidal agent in vitro with immunomodulatory potential on granulomatous inflammation in vivo.
Topics: Animals; Antimalarials; Cells, Cultured; Disease Models, Animal; Doxycycline; Granuloma; Humans; Imm | 2019 |
Vesical paragonimiasis diagnosed by histopathology: a case report.
Topics: Animals; Antiparasitic Agents; Humans; Inflammation; Male; Middle Aged; Paragonimiasis; Paragonimus; | 2014 |
Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.
Topics: Animals; Anthelmintics; Cytokines; Gene Expression Regulation; Granuloma; Inflammation; Mice; Phosph | 2015 |
Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile | 2016 |
Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.
Topics: Animals; Anthelmintics; Brain; Histocytochemistry; Inflammation; Meninges; Neurocysticercosis; Prazi | 2015 |
Rectal inflammatory polyp in a child: an unusual case of polyparasitism.
Topics: Albendazole; Animals; Child; Humans; Inflammation; Male; Polyps; Praziquantel; Rectum; Schistosoma h | 2010 |
Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation.
Topics: Adolescent; Adult; Anemia; Anemia, Iron-Deficiency; Animals; Anthelmintics; Child; Cohort Studies; F | 2006 |
Large cerebral infarction during praziquantel therapy in neurocysticercosis.
Topics: Antiplatyhelmintic Agents; Basal Ganglia; Brain Diseases; Carotid Artery, Internal; Cerebral Angiogr | 1997 |
Dexamethasone increases plasma levels of albendazole.
Topics: Adult; Albendazole; Cysticercosis; Dexamethasone; Drug Therapy, Combination; Female; Humans; Inflamm | 1990 |
Pathology resulting from the administration of a live attenuated anti-Schistosoma haematobium vaccine in baboons.
Topics: Animals; Eosinophilia; Eosinophils; Immunization, Secondary; Inflammation; Leukocyte Count; Papio; P | 1989 |